Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer Disease III: Clinical Manifestations and Complications01:25

Peptic Ulcer Disease III: Clinical Manifestations and Complications

Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk-based pathology reporting after endoscopic submucosal dissection for early gastrointestinal cancer: international consensus standards.

Gut·2026
Same author

Physically intelligent capsule robots with embodied memory and logic in the gastrointestinal tract.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Deployment and clearance of microrobots for localized therapy: past, present and future.

National science review·2026
Same author

Ultrasound-sensitive microrobotic sensor with robust anchoring for long-term digestive lesion assessment.

National science review·2026
Same author

Microswarm bridging effect for dual-surface biofilm eradication in submillimeter infection pockets.

Science advances·2026
Same author

Modular magnetic microrobot system for robust endoluminal navigation and high-radial force stent delivery in complex ductal anatomy.

Science advances·2025

Related Experiment Videos

Bleeding peptic ulcers: the current management.

Philip Wai Yan Chiu1

  • 1Department of Surgery, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China. philipchiu@surgery.cuhk.edu.hk

Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society
|July 2, 2010
PubMed
Summary

Bleeding peptic ulcers are a major cause of hospital admissions. This review covers current management, rebleeding prevention strategies like proton pump inhibitor infusion, and future endoscopic suturing techniques.

Related Experiment Videos

Area of Science:

  • Gastroenterology
  • Endoscopy
  • Surgical Innovation

Background:

  • Peptic ulcer bleeding is a leading cause of emergency admissions globally, with mortality rates up to 10%.
  • Ulcer rebleeding is a significant predictor of mortality in patients with bleeding peptic ulcers.
  • Effective strategies are crucial to reduce rebleeding rates and improve patient outcomes.

Purpose of the Study:

  • To review the current management strategies for bleeding peptic ulcers.
  • To evaluate methods for preventing ulcer rebleeding, including second-look endoscopy and proton pump inhibitor infusion.
  • To explore future advancements in endoscopic hemostasis, such as endoscopic suturing.

Main Methods:

  • Review of current literature on bleeding peptic ulcer management.
  • Analysis of strategies for predicting clinical outcomes.
  • Evaluation of the efficacy of second-look endoscopy and proton pump inhibitor infusion for rebleeding prevention.
  • Discussion of emerging endoscopic techniques like suturing for primary hemostasis.

Main Results:

  • Predictive models can help assess clinical outcomes in bleeding peptic ulcer patients.
  • Scheduled second-look endoscopy and continuous proton pump inhibitor infusion are examined for rebleeding prevention.
  • Endoscopic suturing presents a potential future development for achieving robust primary hemostasis.

Conclusions:

  • Optimizing current management and exploring novel endoscopic techniques are vital for reducing mortality associated with bleeding peptic ulcers.
  • Further research into endoscopic suturing may offer improved solutions for primary hemostasis.
  • Preventing rebleeding remains a critical focus in managing this common gastrointestinal emergency.